The ninth Amanda K. Strous Memorial Field Hockey Scholarship has been awarded to Lilly Cantabene, a junior from York, ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

ESPN broadcaster Hannah Storm, who called the first broadcast of a WNBA game, spoke to PEOPLE about the extended moment women ...

Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

The EPA office at RTP is facing significant cuts as DOGE continues its efforts to fire thousands of government workers across ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.

Eli Lilly (LLY) stock in focus as the company projects earnings headwinds from IPR&D charges estimated at $1.57B for Q1 2025.

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...